Fig. 3
From: SNORD63 and SNORD96A as the non-invasive diagnostic biomarkers for clear cell renal cell carcinoma
The expression of SNORD63 and SNORD96A in formalin fixed paraffin embedding (FFPE), plasma and urinary sediment (US) for ccRCC patients. a The differentially expression of SNORD63 and SNORD96A in FFPE in 54 ccRCC patients compared with adjacent tissues (****P < 0.0001). b The differentially expression of SNORD63 and SNORD96A in plasma in 55 ccRCC patients vs. 40 healthy donors (HD) (ns: no significance, ****P < 0.0001). c The differentially expression of SNORD63 and SNORD96A in US in 75 ccRCC patients vs. 96 healthy donors (HD) (****P < 0.0001)